Romark eyes an EUA with new phase III COVID-19 outpatient data April 14, 2021 By Lee Landenberger No Comments “There is a big need for a drug in outpatients. If you could treat them and keep them out of hospitals, that would be important and play a big role in getting us through this pandemic,” Romark Laboratories LC’s CEO, Marc Ayers, told BioWorld.Read More